Dr. Sindhuri Benjaram, MD

Dr. Benjaram practices at Thomas Memorial Hospital in South Charleston, West Virginia, part of West Virginia University Health System.

Dr. Benjaram's NPI, 1437684040, was assigned on April 21, 2017. Dr. Benjaram holds West Virginia license 29824.

Dr. Benjaram's primary practice is Thomas Memorial Hospital, at 4605 Maccorkle Avenue SW, South Charleston, WV 25309 in Kanawha County. The practice phone is (304) 766-3600.

Dr. Benjaram's primary practice is Thomas Memorial Hospital in South Charleston, West Virginia, part of West Virginia University Health System. The medical group on file is THS Physician Partners, Inc. Dmand AI also links Dr. Benjaram to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benjaram practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Benjaram's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Benjaram is licensed in West Virginia.

CMS data shows 609 Medicare services from Dr. Benjaram across 5 procedure codes in 2024, for 287 Medicare patients. Medicare paid $50,787 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 287 Medicare patients who saw Dr. Benjaram in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Benjaram's median patient age at 72, with 56% women.

In 2024, Dr. Benjaram wrote 421 Medicare Part D claims for 190 patients. 86% of them were for generic drugs. CMS names the drug for 175 of them, across 8 drugs with 11 or more claims each, at $12,073 in total drug cost. In 2023, CMS named 66 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Benjaram for performance year 2024, reported through an alternative payment model (APM). Dr. Benjaram accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Benjaram, published from 2016 to 2022. 2021 was the busiest year, with 3. The most frequent topics are COVID-19, COVID-19 Drug Treatment and Hydroxymethylglutaryl-CoA Reductase Inhibitors. Dr. Benjaram's most frequent co-authors are Prateek Lohia, MD, Murray Norman Ehrinpreis, MD and Milton G. Mutchnick, MD.

CMS Open Payments shows 14 general payments to Dr. Benjaram from 7 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $65.